Foley Mark J

EDGAR CIK 0001529196

Revance Therapeutics, Inc. - RVNC

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
CEO
Direct Buys
1
$209,400
30,000 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/06/2024
03/08/2024
Buy
30,000 @ $6.98
 $209,400 1,015,468 (3.04%) Direct